Government-run pharmacare won’t help
A new national drug program will bring additional costs to taxpayers, and therefore does nothing to change the incentives which encourage governments to restrict access to the most expensive new drugs in the first place.
VANCOUVER, B.C.—The Canadian Centre for Policy Alternatives (CCPA) recently published a report advocating for a national universal publicly-funded pharmacare program. The CCPA suggests that a universal government-run drug program would benefit patients while saving billions for taxpayers. H...
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
